Vulvar cancer is a rare condition, accounting for 4% of gynecological cancers and less than 1% of all female cancers.We conducted a retrospective descriptive study of 30 observations of vulvar cancer collected in the Obstetrics and Gynecology Department of Monastir over a period of 16 years. The objectives were to describe the epidemiologic-clinical profile and specify the therapeutic modalities of vulvar cancer.The average age of patients was 70 years. The average delay to consultation was 7 months. Clinical symptoms were dominated by pruritus and the perception of a vulvar tumour. Ulcerative-bourgeous forms accounted for 50% of cases. Multifocal involvement was the most frequent, with a mean size of 4 cm.Overall survival at 5 years was 72.2%.Preventing vulvar cancer through early detection of at-risk groups and precancerous lesions remains the best way of combating this disease.